The polyketide pks1 contributes to biofilm formation in Mycobacterium tuberculosis

Journal of Bacteriology

Volumn 194, Issue 3, 2012, Pages 715-721

  Pang, Jennifer M ^a,b   Layre, Emilie ^c   Sweet, Lindsay ^c   Sherrid, Ashley ^a,b,e   Moody, D Branch ^c   Ojha, Anil ^d   Sherman, David R ^a,b  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; PHENOLIC GLYCOLIPID; POLYKETIDE SYNTHASE; POLYKETIDE SYNTHASE 1; POLYKETIDE SYNTHASE 15; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM MUTANT; BIOFILM; CONTROLLED STUDY; GENETIC SCREENING; GENOTYPE; IN VITRO STUDY; LIPOGENESIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHYLOGEOGRAPHY; PRIORITY JOURNAL; TRANSPOSON;

BACTERIAL PROTEINS; BIOFILMS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; POLYKETIDE SYNTHASES; POLYKETIDES; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84855945113     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.06304-11     Document Type: Article

References (42)

1. Adams KN, et al. 2011. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145:39-53.
2. Boshoff HI, Barry CE, III. 2005. Tuberculosis-metabolism and respiration in the absence of growth. Nat. Rev. Microbiol. 3:70-80.
3. Carter G, Wu M, Drummond DC, Bermudez LE. 2003. Characterization of biofilm formation by clinical isolates of Mycobacterium avium. J. Med. Microbiol. 52:747-752.
4. Chopra T, Gokhale RS. 2009. Polyketide versatility in the biosynthesis of complex mycobacterial cell wall lipids. Methods Enzymol. 459:259-294.
5. Clay H, Volkman HE, Ramakrishnan L. 2008. Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity 29:283-294.
6. Comas I, et al. 2010. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat. Genet. 42:498-503.
7. Constant P, et al. 2002. Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. J. Biol. Chem. 277:38148-38158.
8. Davies D. 2003. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov. 2:114-122.
9. Di Bonaventura G, et al. 2008. Influence of temperature on biofilm formation by Listeria monocytogenes on various food-contact surfaces: relationship with motility and cell surface hydrophobicity. J. Appl. Microbiol. 104:1552-1561.
10. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
11. Fedtke I, Gotz F, Peschel A. 2004. Bacterial evasion of innate host defenses-the Staphylococcus aureus lesson. Int. J. Med. Microbiol. 294: 189-194.
12. Fey PD. 2010. Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections? Curr. Opin. Microbiol. 13: 610-615.
13. Ford CB, et al. 2011. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat. Genet. 43:482-486.
14. Guinn KM, et al. 2004. Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol. Microbiol. 51:359-370.
15. Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2:95-108.
16. Hershberg R, et al. 2008. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol. 6:e311.
17. Hu Y, et al. 2000. Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide. J. Bacteriol. 182:6358-6365.
18. Hunter RL, Olsen M, Jagannath C, Actor JK. 2006. Trehalose 6,6′-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice. Am. J. Pathol. 168:1249-1261.
19. Hunter RL, Olsen MR, Jagannath C, Actor JK. 2006. Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann. Clin. Lab. Sci. 36:371-386.
20. Jackson M, Stadthagen G, Gicquel B. 2007. Long-chain multiple methyl-branched fatty acid-containing lipids of Mycobacterium tuberculosis: biosynthesis, transport, regulation and biological activities. Tuberculosis (Edinb.) 87:78-86.
21. Jenke-Kodama H, Dittmann E. 2009. Evolution of metabolic diversity: insights from microbial polyketide synthases. Phytochemistry 70: 1858-1866.
22. Kim KS, Salton MR, Barksdale L. 1976. Ultrastructure of superficial mycosidic integuments of Mycobacterium sp. J. Bacteriol. 125:739-743.
23. Layre E, et al. A comparative lipidomics platform for chemotaxic analysis of Mycobacterium tuberculosis. Chem. Biol., in press.
24. Lewis K. 2008. Multidrug tolerance of biofilms and persister cells. Curr. Top. Microbiol. Immunol. 322:107-131.
25. Middlebrook G, Dubos RJ, Pierce C. 1947. Virulence and morphological characteristics of mammalian tubercle bacilli. J. Exp. Med. 86: 175-184.
26. Moss SJ, Martin CJ, Wilkinson B. 2004. Loss of co-linearity by modular polyketide synthases: a mechanism for the evolution of chemical diversity. Nat. Prod. Rep. 21:575-593.
27. Ojha AK, Trivelli X, Guerardel Y, Kremer L, Hatfull GF. 2010. Enzymatic hydrolysis of trehalose dimycolate releases free mycolic acids during mycobacterial growth in biofilms. J. Biol. Chem. 285: 17380-17389.
28. Ojha A, et al. 2005. GroEL1: a dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria. Cell 123: 861-873.
29. Ojha AK, et al. 2008. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol. Microbiol. 69:164-174.
30. Olano C, Mendez C, Salas JA. 2010. Post-PKS tailoring steps in natural product-producing actinomycetes from the perspective of combinatorial biosynthesis. Nat. Prod. Rep. 27:571-616.
31. O'Toole G, Kaplan HB, Kolter R. 2000. Biofilm formation as microbial development. Annu. Rev. Microbiol. 54:49-79.
32. Parsek MR, Singh PK. 2003. Bacterial biofilms: an emerging link to disease pathogenesis. Annu. Rev. Microbiol. 57:677-701.
33. Reddy TB, et al. 2009. TB database: an integrated platform for tuberculosis research. Nucleic Acids Res. 37:D499-D508.
34. Reed MB, et al. 2004. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431:84-87.
35. Russell DG, Barry CE, III, Flynn JL. 2010. Tuberculosis: what we don't know can, and does, hurt us. Science 328:852-856.
36. Rustad TR, Sherrid AM, Minch KJ, Sherman DR. 2009. Hypoxia: a window into Mycobacterium tuberculosis latency. Cell. Microbiol. 11: 1151-1159.
37. Sassetti CM, Boyd DH, Rubin EJ. 2003. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 48: 77-84.
38. Sule P, et al. 2009. A combination of assays reveals biomass differences in biofilms formed by Escherichia coli mutants. Lett. Appl. Microbiol. 49: 299-304.
39. Tang GL, Cheng YQ, Shen B. 2004. Leinamycin biosynthesis revealing unprecedented architectural complexity for a hybrid polyketide synthase and nonribosomal peptide synthetase. Chem. Biol. 11:33-45.
40. Tobin DM, et al. 2010. The Ita4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140:717-730.
41. Trivedi OA, et al. 2004. Enzymic activation and transfer of fatty acids as acyl-adenylates in mycobacteria. Nature 428:441-445.
42. Weissman KJ, Leadlay PF. 2005. Combinatorial biosynthesis of reduced polyketides. Nat. Rev. Microbiol. 3:925-936.